| 1 | [SID56463137] | Active | Potency | 0.0073 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | Potency | 0.0073 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 2 | [SID56463137] | Active | Potency | 0.0092 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | Potency | 0.0092 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID56463137] | Active | Potency | 0.0146 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | Potency | 0.0146 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID56463137] | Active | CC50 | 0.05 | Vero 76 Cytoxicity Assay for VEEV Compounds [AID588719, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | CC50 | 0.05 [uM] | | BioAssay | Vero 76 Cytoxicity Assay for VEEV Compounds | | AID | 588719 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID56463137] | Active | Potency | 0.058 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | Potency | 0.058 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID56463137] | Active | AbsAC35_uM | 0.09 | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_Dose_CherryPick_Activity [AID686920, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | AbsAC35_uM | 0.09 [uM] | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_Dose_CherryPick_Activity | | AID | 686920 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID56463137] | Active | AC50 | 0.16 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | AC50 | 0.16 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID56463137] | Active | AC50 | 0.16 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | AC50 | 0.16 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID56463137] | Active | IC50 | 0.16 | Dose response counterscreen of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay [AID489020, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | IC50 | 0.16 [uM] | | BioAssay | Dose response counterscreen of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay | | AID | 489020 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID56463137] | Active | IC50 | 0.16 | Dose response confirmation of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay [AID489034, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | IC50 | 0.16 [uM] | | BioAssay | Dose response confirmation of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay | | AID | 489034 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID56463137] | Active | IC50 | 0.45 | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay [AID624167, Type: confirmatory] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | IC50 | 0.45 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule Peg3 Promoter Inhibitor hits in a screening assay | | AID | 624167 | | BioAssay type | confirmatory | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 12 | [SID56463137] | Active | IC50 | 1.66 | Dose response confirmation of uHTS of chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay [AID489004, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | IC50 | 1.66 [uM] | | BioAssay | Dose response confirmation of uHTS of chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay | | AID | 489004 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID56463137] | Active | | | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504539, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504539 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID56463137] | Active | | | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_CherryPick_Activity [AID504592, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_CherryPick_Activity | | AID | 504592 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID56463137] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay [AID504607, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay | | AID | 504607 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID56463137] | Active | | | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity [AID488862, Type: screening] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488862 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID56463137] | Active | | | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation [AID435003, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation | | AID | 435003 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID56463137] | Active | | | Single concentration confirmation of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation [AID435020, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Single concentration confirmation of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation | | AID | 435020 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID56463137] | Active | | | uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation [AID435022, Type: screening] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation | | AID | 435022 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID85787536] | Active | | | Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells [AID2275, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85787536 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells | | AID | 2275 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID56463137] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID56463137] | Active | | | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors [AID602141, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors | | AID | 602141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID56463137] | Active | | | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity [AID651610, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651610 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID56463137] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts [AID651611, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts | | AID | 651611 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID56463137] | Active | | | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity [AID651661, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651661 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID56463137] | Active | | | MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity [AID651687, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651687 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID56463137] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID56463137] | Active | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID56463137] | Active | | | Counterscreen for inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID652007, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 652007 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID56463137] | Active | | | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID652008, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 652008 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID56463137] | Active | | | QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1). [AID1906, Type: screening] | cathepsin L1 [Homo sapiens] [gi:55958172] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1). | | AID | 1906 | | BioAssay type | screening | | Target | cathepsin L1 [Homo sapiens] [gi:55958172] | | PubMed | | | Data Table |  |
|
| 32 | [SID56463137] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 33 | [SID56463137] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 34 | [SID56463137] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 35 | [SID56463137] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 36 | [SID56463137] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 37 | [SID56463137] | Active | | | Single concentration confirmation of uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID651580, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 651580 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 38 | [SID56463137] | Active | | | Single concentration confirmation of uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID651580, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 651580 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 39 | [SID56463137] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 40 | [SID56463137] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 41 | [SID56463137] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 42 | [SID56463137] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 43 | [SID56463137] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 44 | [SID56463137] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 45 | [SID56463137] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 46 | [SID56463137] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 47 | [SID56463137] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 48 | [SID56463137] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504905, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504905 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 49 | [SID56463137] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504905, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504905 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 50 | [SID56463137] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504905, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56463137 | | CID | 9828429 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504905 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|